Birth Outcomes and Rehospitalizations Among Pregnant Women With Rheumatoid Arthritis and Systemic Lupus Erythematosus and Their Offspring

Arthritis Care Res (Hoboken)Published Retrospective cohort study

Authors' conclusion

Women with RA or SLE and their infants experienced adverse outcomes, particularly infants of women with SLE. Maternal/infant rehospitalization was more common; most marked in the early months postpartum.

Study context

Population
Women with singleton births 1987–2014 in Washington State, and their infants
Exposure
Women with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) vs unexposed women
  • RAn = 1,223
  • SLEn = 1,354
Outcome
Obstetric/birth outcomes and rehospitalization of mothers and infants, including cause-specific hospitalizations <2 years postpartum
Follow-up
<2 years postpartum
Methodological detailspopulation-based, linked vital and hospital discharge records
  • Population-based
  • Linked vital and hospital discharge records

Main finding

As reported in the abstract

Maternal rehospitalization · <6 months postpartum
Each group vs unexposedAdjusted relative risk (95% CI)
RA
2.22(1.62–3.04)
SLE
2.78(2.15–3.59)

Observational data: associations, not effects.

Further findings

OutcomeSLEUnexposedEstimate
Maternal postpartum rehospitalization for musculoskeletal conditionsRAvs UnexposedHR 19.1 (95% CI 13.6–26.8)
Maternal postpartum rehospitalization for musculoskeletal conditionsSLEvs UnexposedHR 29.8 (95% CI 22.1–40.1)
Infant malformationsSLEvs Unexposed9%6%RR 1.46 (95% CI 1.21–1.75)
Infant mortality · <2 yearsSLEvs UnexposedRR 2.11 (95% CI 1.21–3.67)

Infant rehospitalizations · first year of life

More frequent in infants of women with SLE

Original publication

Birth Outcomes and Rehospitalizations Among Pregnant Women With Rheumatoid Arthritis and Systemic Lupus Erythematosus and Their Offspring. Arthritis Care Res (Hoboken). Published 1 March 2023. doi:10.1002/acr.25087

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.